CFDE Data Portal | Search LINC01533

	Label	Description
	LINC01533 Gene (Entity type)	ENSG00000267779 - long intergenic non-protein coding RNA 1533
	GSE207410 GSE207411 ARID1A knockdown 5 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE206931 WDR5 inhibition WIN 3 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 0 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE146982 metformin 7 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE230865 EYA2 knockdown 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 3 v 13 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Testis 20-29 vs 50-59 Down Gene Set (Entity type)	A Gene Set from GTEx
	GSE139540 menadione 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239651 ispinesib 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC01533

ENSG00000267779 - long intergenic non-protein coding RNA 1533

GSE207410 GSE207411 ARID1A knockdown 5 v 3 human up

A Gene Set from LINCS

GSE206931 WDR5 inhibition WIN 3 v 6 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 0 v 6 human dn

A Gene Set from LINCS

GSE146982 metformin 7 v 5 human up

A Gene Set from LINCS

GSE230865 EYA2 knockdown 3 v 2 human dn

A Gene Set from LINCS

GSE252944 AKT inhibition 3 v 13 human up

A Gene Set from LINCS

GTEx Testis 20-29 vs 50-59 Down

A Gene Set from GTEx

GSE139540 menadione 3 v 2 human dn

A Gene Set from LINCS

GSE239651 ispinesib 1 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.